ER-localized aminopeptidases in ankylosing spondylitis

强直性脊柱炎中内质网定位的氨肽酶

基本信息

  • 批准号:
    8284209
  • 负责人:
  • 金额:
    $ 29.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-07-15 至 2015-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Ankylosing spondylitis (AS) is a painful, incurable autoimmune disease that affects millions of people worldwide. Although it is clear that both environmental and genetic factors are involved in the disease, the cause and pathogenesis of AS remain unclear. A strong link with the MHC class I allele HLA-B27 has implicated antigen processing as an underlying factor, and this hypothesis was strengthened by the recent demonstration that polymorphisms in ERAP1 (an aminopeptidase that we and others have shown is associated with antigen processing) affect the risk of developing AS. We hypothesize that ERAP1 polymorphisms either directly or indirectly affect substrate selection and trimming, so that different ERAP1 alleles alter the levels of arthritogenic or protective peptides presented on HLA-B27. We will test this hypothesis using biochemical assays for substrate specificity, cultured cells to measure effects on antigen processing, and transgenic mice to test effects on disease in vivo. We will also test the effects of ERAP1 polymorphisms on other pathways that have been proposed to affect AS pathogenesis, including the assembly and stability of HLA- B27 and shedding of cytokine receptors. The Aims of this project are to determine the functional effects of ERAP1 polymorphisms and to understand the molecular pathogenesis of AS. The long-term goals of this project are to predict the risk of AS in individuals, and to develop methods to prevent and treat AS. We will also apply the understanding of AS pathogenesis to other autoimmune diseases that are linked to MHC class I alleles. PUBLIC HEALTH RELEVANCE: Ankylosing spondylitis is a painful, chronic, incurable autoimmune disease that affects millions of people worldwide. Although it is clear that both genetic and environmental factors are involved, the underlying causes and mechanisms of the disease are not known. In this project I will take advantage of a recently-described association with the gene ERAP1 to identify mechanisms that cause ankylosing spondylitis, with the ultimate goal of developing new techniques to predict the risk of ankylosing spondylitis, and to prevent and treat the disease.
描述(申请人提供):强直性脊柱炎(AS)是一种痛苦的、不可治愈的自身免疫性疾病,影响着全球数百万人。虽然环境因素和遗传因素都与该病有关,但AS的病因和发病机制尚不清楚。与MHC-I类等位基因HLA-B27有很强的联系,这意味着抗原处理是一个潜在的因素,最近有证据表明ERAP1(我们和其他人已经证明与抗原处理相关的一种氨基肽酶)的多态性影响发生AS的风险,这一假设得到了加强。我们假设ERAP1基因的多态直接或间接地影响底物的选择和修剪,因此不同的ERAP1等位基因改变了人类白细胞抗原B27上的致关节炎或保护性多肽的水平。我们将使用底物特异性的生化分析来验证这一假设,用培养细胞来测量对抗原处理的影响,并用转基因小鼠来测试体内对疾病的影响。我们还将测试ERAP1基因多态性对其他已被认为影响AS发病机制的途径的影响,包括HLA-B27的组装和稳定性以及细胞因子受体的脱落。本项目的目的是确定ERAP1基因多态性的功能效应,并了解AS的分子发病机制。该项目的长期目标是预测个体AS的风险,并开发预防和治疗AS的方法。我们还将把对AS发病机制的理解应用于其他与MHC I类等位基因相关的自身免疫性疾病。 公共卫生相关性:强直性脊柱炎是一种痛苦、慢性、无法治愈的自身免疫性疾病,影响着全球数百万人。虽然很明显,遗传和环境因素都涉及,但这种疾病的根本原因和机制尚不清楚。在这个项目中,我将利用最近描述的与ERAP1基因的关联来确定导致强直性脊柱炎的机制,最终目标是开发新的技术来预测强直性脊柱炎的风险,并预防和治疗这种疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andrea na Amalfitano其他文献

Andrea na Amalfitano的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Andrea na Amalfitano', 18)}}的其他基金

ER-Localized Aminopeptidases in Ankylosing Spondylitis
强直性脊柱炎中的内质网定位氨肽酶
  • 批准号:
    8670551
  • 财政年份:
    2010
  • 资助金额:
    $ 29.55万
  • 项目类别:
ER-localized aminopeptidases in ankylosing spondylitis
强直性脊柱炎中内质网定位的氨肽酶
  • 批准号:
    8476986
  • 财政年份:
    2010
  • 资助金额:
    $ 29.55万
  • 项目类别:
ER-localized aminopeptidases in ankylosing spondylitis
强直性脊柱炎中内质网定位的氨肽酶
  • 批准号:
    8110051
  • 财政年份:
    2010
  • 资助金额:
    $ 29.55万
  • 项目类别:
ER-localized aminopeptidases in ankylosing spondylitis
强直性脊柱炎中内质网定位的氨肽酶
  • 批准号:
    7983691
  • 财政年份:
    2010
  • 资助金额:
    $ 29.55万
  • 项目类别:
Adenovirus vectors and complement system
腺病毒载体和补体系统
  • 批准号:
    6861181
  • 财政年份:
    2005
  • 资助金额:
    $ 29.55万
  • 项目类别:
Adenovirus vectors and complement system
腺病毒载体和补体系统
  • 批准号:
    7192472
  • 财政年份:
    2005
  • 资助金额:
    $ 29.55万
  • 项目类别:
Adenovirus vectors and complement system
腺病毒载体和补体系统
  • 批准号:
    7147257
  • 财政年份:
    2005
  • 资助金额:
    $ 29.55万
  • 项目类别:
Adenovirus vectors and complement system
腺病毒载体和补体系统
  • 批准号:
    7178508
  • 财政年份:
    2005
  • 资助金额:
    $ 29.55万
  • 项目类别:
Adoptive Immunotherapy with Recombinant Adenvirus Vector
重组腺病毒载体的过继免疫治疗
  • 批准号:
    6989595
  • 财政年份:
    2004
  • 资助金额:
    $ 29.55万
  • 项目类别:
MODIFIED ADENOVIRUS VECTORS FOR USE IN GENE THERAPY
用于基因治疗的修饰腺病毒载体
  • 批准号:
    2906074
  • 财政年份:
    1998
  • 资助金额:
    $ 29.55万
  • 项目类别:

相似海外基金

Determining the mechanism of action of cis-acting modifiers on the age of onset of Huntington Disease
确定顺式作用修饰剂对亨廷顿病发病年龄的作用机制
  • 批准号:
    417256
  • 财政年份:
    2019
  • 资助金额:
    $ 29.55万
  • 项目类别:
    Studentship Programs
Effect of age of onset of contraception use on brain functioning.
避孕开始年龄对大脑功能的影响。
  • 批准号:
    511267-2017
  • 财政年份:
    2017
  • 资助金额:
    $ 29.55万
  • 项目类别:
    University Undergraduate Student Research Awards
Non-random occurrence and early age of onset of diverse lymphoid cancers in families supports the existence of genetic risk factors for multiple lymphoid cancers.
家族中多种淋巴癌的非随机发生和发病年龄较早,支持多种淋巴癌存在遗传危险因素。
  • 批准号:
    347105
  • 财政年份:
    2016
  • 资助金额:
    $ 29.55万
  • 项目类别:
Polish-German Child Bilingualism: The Role of Age of Onset for Long-Term Achievement
波兰-德国儿童双语:发病年龄对长期成就的作用
  • 批准号:
    277135691
  • 财政年份:
    2015
  • 资助金额:
    $ 29.55万
  • 项目类别:
    Research Grants
Bioinformatics strategies to relate age of onset with gene-gene interaction
将发病年龄与基因间相互作用联系起来的生物信息学策略
  • 批准号:
    9097781
  • 财政年份:
    2015
  • 资助金额:
    $ 29.55万
  • 项目类别:
Early Age-of-Onset AD: Clinical Heterogeneity and Network Degeneration
早期 AD 发病年龄:临床异质性和网络退化
  • 批准号:
    9212684
  • 财政年份:
    2014
  • 资助金额:
    $ 29.55万
  • 项目类别:
Early Age-of-Onset AD: Clinical Heterogeneity and Network Degeneration
早期 AD 发病年龄:临床异质性和网络退化
  • 批准号:
    8696557
  • 财政年份:
    2014
  • 资助金额:
    $ 29.55万
  • 项目类别:
Effects of delaying age of onset of binge drinking on adolescent brain development: A proposal to add neuroimaing measures to the CO-Venture Trial.
延迟酗酒的发病年龄对青少年大脑发育的影响:在 CO-Venture 试验中添加神经影像测量的建议。
  • 批准号:
    267251
  • 财政年份:
    2012
  • 资助金额:
    $ 29.55万
  • 项目类别:
    Operating Grants
Stress Effects on Alcohol Consumption: Age of onset and genes in heavy drinkers
压力对饮酒的影响:酗酒者的发病年龄和基因
  • 批准号:
    8606722
  • 财政年份:
    2012
  • 资助金额:
    $ 29.55万
  • 项目类别:
Marijuana: Neurobiologic Correlates of Age of Onset
大麻:发病年龄的神经生物学相关性
  • 批准号:
    8644793
  • 财政年份:
    2012
  • 资助金额:
    $ 29.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了